Fungisolve Tolnaftate Antifungal
NDC Package 70242-108-01
Package Information
Fungisolve Tolnaftate Antifungal is adults and children 12 years and over wash the affected area and dry thoroughly apply a thin layer over affected area twice daily morning and night supervis children in the use of this product for athlete's foot, pay special attention to spaces between the toes: wear well-fitting ventilated shoes and change shoes and socks at least once a day. Marketed by Dannso Corp./d.b.a. Essential Products, this product is identified by NDC 70242-108 and is authorized under FDA application part333C.
Identification & Billing
- RxCUI: 103951 - tolnaftate 1 % Topical Cream
- RxCUI: 103951 - tolnaftate 10 MG/ML Topical Cream
- RxCUI: 1790292 - FUNGISOLVE 1 % Topical Cream
- RxCUI: 1790292 - tolnaftate 10 MG/ML Topical Cream [Fungisolve]
- RxCUI: 1790292 - Fungisolve 1 % Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70242 - Dannso Corp./d.b.a. Essential Products
- 70242-108 - Fungisolve Tolnaftate Antifungal
- 70242-108-01 - 28 g in 1 TUBE
- 70242-108 - Fungisolve Tolnaftate Antifungal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70242-108-01 identifies a specific commercial package of 28 g in 1 tube of Fungisolve Tolnaftate Antifungal, labeled by Dannso Corp./d.b.a. Essential Products. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dannso Corp./d.b.a. Essential Products on March 16, 2011. The current certification is valid through December 31, 2017.
How is this Dannso Corp./d.b.a. Essential Products product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70242010801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.